Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1/2 5 Phase 3 3 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 45 pembrolizumab 40 Magnetic Resonance Spectroscopy 32 Cyclophosphamide 31 Biopsy 31 fludarabine 27 Cetuximab 19 Cisplatin 18 Carboplatin 18 atezolizumab 15 Bevacizumab 15 Fluorouracil 14 venetoclax 13 Radiation 13 Leucovorin 13 fludarabine phosphate 12 Radiotherapy 12 Gemcitabine 12 Pemetrexed 11 Oxaliplatin 11 Nivolumab 11 Cytarabine 10 130-nm albumin-bound paclitaxel 10 Prednisone 9 Paclitaxel 9 Irinotecan 9 Fulvestrant 9 Radiosurgery 8 Platinum 8 Immunoglobulin G 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × amivantamab × 30 days × Clear all

NCT02609776 2026-06-05

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting

751 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡